Clinical Trials Directory

Trials / Completed

CompletedNCT04402606

Study on Skin Toxicities Induced by Cancer Treatments

DERMACLIC : Study on Skin Toxicities Induced by Cancer Treatments

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
292 (actual)
Sponsor
Institut Curie · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The skin toxicities will be evaluated on patient (male or female) with an indication of cancer treatment in the case of solid tumor of the breast, or lung.

Conditions

Interventions

TypeNameDescription
OTHEREvaluation on skin toxicitiesMeasurements will be carried out using specific tools, such as the cutaneous ultrasound system (measurement of the skin layers thicknesses, the cutometer (measurement of the elasticity of the skin), the corneometer (measurement of the hydration of the skin), the pH meter (measuring the pH of the skin), the colorimeter (measuring the color of the skin), the tewameter (measuring the insensible loss of water), the sebometer (measuring sebum).

Timeline

Start date
2020-11-25
Primary completion
2020-11-25
Completion
2024-04-15
First posted
2020-05-27
Last updated
2024-04-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04402606. Inclusion in this directory is not an endorsement.

Study on Skin Toxicities Induced by Cancer Treatments (NCT04402606) · Clinical Trials Directory